These findings suggest that interactions between CYP1A1 polymorphisms and PCBs could be involved in the development of breast cancer, and genotyping for CYP1A1 could help to resolve inconsistencies in past epidemiologic studies. The gene discussed is CYP1A1; the disease is breast cancer.